73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Differences in T cells' functional state determine resistance to cancer therapy

Differences in T cells' functional state determine resistance to cancer therapy

by Massachusetts Institute of TechnologyThe researchers took this image of a tumor using immunofluorescence, a technique that allows them to stain tissue sections with fluorescently-labeled antib

Differences in T cells' functional state determine resistance to cancer therapy

by Massachusetts Institute of TechnologyThe researchers took this image of a tumor using immunofluorescence, a technique that allows them to stain tissue sections with fluorescently-labeled antib
Miami's Little Haiti joins global effort to end cervical cancer

Miami's Little Haiti joins global effort to end cervical cancer

by Verónica ZaragoviaCredit: Unsplash/CC0 Public DomainMore than 300,000 women around the world die from cervical cancer each year. In the U.S., women of Haitian descent are diagnosed with it at highe

Miami's Little Haiti joins global effort to end cervical cancer

by Verónica ZaragoviaCredit: Unsplash/CC0 Public DomainMore than 300,000 women around the world die from cervical cancer each year. In the U.S., women of Haitian descent are diagnosed with it at highe
New, revised topics released in ACR appropriateness criteria

New, revised topics released in ACR appropriateness criteria

(HealthDay)—The latest edition of the American College of Radiology (ACR) Appropriateness Criteria has been released and includes 188 diagnostic imaging and interventional radiology topics, with 908 c

New, revised topics released in ACR appropriateness criteria

(HealthDay)—The latest edition of the American College of Radiology (ACR) Appropriateness Criteria has been released and includes 188 diagnostic imaging and interventional radiology topics, with 908 c
First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

by Perelman School of Medicine at the University of PennsylvaniaSafety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with

First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

by Perelman School of Medicine at the University of PennsylvaniaSafety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with
Understanding early effects of psoriasis drug offers potential for personalized treatment

Understanding early effects of psoriasis drug offers potential for personalized treatment

by King's College LondonDiagram showing the early effects of therapeutic IL-23 inhibition. Left: in lesional psoriasis skin, IL-23 drives the differentiation of T17 cells. Right: following IL

Understanding early effects of psoriasis drug offers potential for personalized treatment

by King's College LondonDiagram showing the early effects of therapeutic IL-23 inhibition. Left: in lesional psoriasis skin, IL-23 drives the differentiation of T17 cells. Right: following IL
Study shows promise of new anti-KRAS drug for pancreatic cancer

Study shows promise of new anti-KRAS drug for pancreatic cancer

by Perelman School of Medicine at the University of PennsylvaniaMRTX1133 reduces metastatic burden in a tail vein model. (A) Representative brightfield images of lungs from vehicle and MRTX1133 (

Study shows promise of new anti-KRAS drug for pancreatic cancer

by Perelman School of Medicine at the University of PennsylvaniaMRTX1133 reduces metastatic burden in a tail vein model. (A) Representative brightfield images of lungs from vehicle and MRTX1133 (
Targeted therapy extends survival in cancers of unknown primary

Targeted therapy extends survival in cancers of unknown primary

by Julia Bird, Universitätsklinikum HeidelbergProgression-free survival in the intention-to-treat population, category 1 patients. Credit:The Lancet(2024). DOI: 10.1016/S0140-6736(24)00814

Targeted therapy extends survival in cancers of unknown primary

by Julia Bird, Universitätsklinikum HeidelbergProgression-free survival in the intention-to-treat population, category 1 patients. Credit:The Lancet(2024). DOI: 10.1016/S0140-6736(24)00814
p53 mutations in 10,000 cancer patients shed new light on gene's function

p53 mutations in 10,000 cancer patients shed new light on gene's function

by Molly Chiu,Baylor College of MedicineKiller T cells surround a cancer cell. Credit: NIHOne of the most extensively studied genes in cancer, TP53 is well known for its role as a tumor suppress

p53 mutations in 10,000 cancer patients shed new light on gene's function

by Molly Chiu,Baylor College of MedicineKiller T cells surround a cancer cell. Credit: NIHOne of the most extensively studied genes in cancer, TP53 is well known for its role as a tumor suppress
CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in clinical trial

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in clinical trial

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Texas Children's Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Child

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in clinical trial

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Texas Children's Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Child
New research may hold key to better treatments for aggressive brain cancer

New research may hold key to better treatments for aggressive brain cancer

by Spectrum HealthPrakash Chinnaiyan, M.D., a physician scientist in the Department of Radiation Oncology at Corewell Health in Southeast, Mich. Credit: Elizabeth Debeliso, Corewell HealthFor decades,

New research may hold key to better treatments for aggressive brain cancer

by Spectrum HealthPrakash Chinnaiyan, M.D., a physician scientist in the Department of Radiation Oncology at Corewell Health in Southeast, Mich. Credit: Elizabeth Debeliso, Corewell HealthFor decades,
Modest rise in UK cancer cases but substantial decline in deaths over last 25 years: Study

Modest rise in UK cancer cases but substantial decline in deaths over last 25 years: Study

by British Medical JournalCredit: Unsplash/CC0 Public DomainCases of cancer among UK men and women aged 35-69 years have seen a modest rise over the last quarter of a century, but there has also

Modest rise in UK cancer cases but substantial decline in deaths over last 25 years: Study

by British Medical JournalCredit: Unsplash/CC0 Public DomainCases of cancer among UK men and women aged 35-69 years have seen a modest rise over the last quarter of a century, but there has also